← Eichor
Condition: Graft Versus Host Disease Gvhd Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Graft Versus Host Disease Gvhd

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3 · 175 location(s) · Janssen Research & Development, LLC · NCT01804686Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hemato
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07235501Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute
Phase 2 · 11 location(s) · ReAlta Life Sciences, Inc. · NCT06343792Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation
Phase 4 · 2 location(s) · Hospices Civils de Lyon · NCT05743400Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Phase 2 · 24 location(s) · Novartis Pharmaceuticals · NCT07354074Quebec Low Back Pain Study: Core Dataset
Phase N/A · 1 location(s) · Laval University · NCT04791891Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT07011810Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens
Phase 2/Phase 3 · 56 location(s) · University Hospital, Angers · NCT02416388Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis
Phase 4 · 1 location(s) · Chinese PLA General Hospital · NCT07045155oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05170347A Study of Ruxolitinib in Patients With Graft-Versus Host Disease
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07594587Laparoendoscopic Rendezvous for Concomitant Gall Bladder Stones and Common Bile Duct Stones
NA · 1 location(s) · Minia University · NCT07008170LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Phase 2 · 1 location(s) · Steven Hays, MD · NCT06018766Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyc
Phase 1 · 2 location(s) · University of Kansas Medical Center · NCT03533816A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Phase 2 · 121 location(s) · Syndax Pharmaceuticals · NCT04710576BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
Phase 2 · 1 location(s) · BioPhoenix Co., Ltd. · NCT07246031IS-free Treg HaploHCT
Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT04678401A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD
NA · 1 location(s) · Anhui Provincial Hospital · NCT06321198A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Di
Phase 2 · 41 location(s) · Incyte Corporation · NCT07124078Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Vir
Phase 4 · 1 location(s) · Beijing Children's Hospital · NCT07029958Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )
Phase 2 · 1 location(s) · Daihong Liu · NCT07340723A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT
Phase 2 · 1 location(s) · WeiShi · NCT07606703The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
Phase N/A · 1 location(s) · Indiana University · NCT04700657Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versu
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06996119An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Phase 3 · 19 location(s) · Dompé Farmaceutici S.p.A · NCT07395232Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus H
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07366801Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT06392711Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT
Phase 3 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07689630
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.